Pharmaceuticals

AstraZeneca (AZN) recently suffered a major setback with the US Food and Drug Administration (FDA) issuing a complete response letter (CRL) for Brilinta (ticagrelor). The company was seeking approval for the use of Brilinta in the treatment of acute coronary syndrome (ACS). The agency has asked...

AstraZeneca (AZN) recently suffered a major setback with the US Food and Drug Administration (FDA) issuing a complete response letter (CRL) for Brilinta (ticagrelor). The company was seeking approval for the use of Brilinta in the treatment of acute coronary syndrome (ACS). The agency has asked...

Amgen (AMGN) recently presented much-awaited results on Xgeva (denosumab) from a phase III study that was conducted in 1,432 men with castrate-resistant prostate cancer. Top-line results from the ‘147 study showed that Xgeva improved median bone metastasis-free survival by 4.2 months compared to...

Cusick's Corner The market stayed in this consolidative grind going into the After Hours. It was a fair and orderly Quad Witching, leaving us all with a lot of decisions to make over the weekend and into the holiday week. Right now the market is clearly stuck with overhead resistance in place, SPX...

Amgen (AMGN) recently presented much-awaited results on Xgeva (denosumab) from a phase III study that was conducted in 1,432 men with castrate-resistant prostate cancer. Top-line results from the ‘147 study showed that Xgeva improved median bone metastasis-free survival by 4.2 months compared to...

Anthony Scaramucci is on CNBC Fast Money's and he is giving some trades for 2011. Scaramucci said he likes Pfizer (NYSE: PFE), Altria (NYSE: MO), Novagold Resources (NYSE: NG) and Coach (NYSE: COH) for 2011. Scaramucci said the three themes for 2011 are reflation, gold, and the expanding middle...

California-based aesthetic laser treatments provider Solta Medical (SLTM) has reached an important landmark as the company has shipped its one millionth consumable treatment tip for its coveted Thermage and Fraxel devices for skin tightening and resurfacing. Consumable treatment tips attached...

California-based aesthetic laser treatments provider Solta Medical (SLTM) has reached an important landmark as the company has shipped its one millionth consumable treatment tip for its coveted Thermage and Fraxel devices for skin tightening and resurfacing. Consumable treatment tips attached...

Shares of Amarin Corporation PLC (Nasdaq: AMRN) ended the Friday trading session up 13.1% at $7.18 per share. Today's trading range for shares of Amarin Corporation PLC was between $6.29 and a 52-week high of $7.25 per share. The consensus price target of analysts covering the company's stock is $7...

California-based diagnostic products maker Gen-Probe Inc (GPRO) has acquired Wisconsin-based privately-held specialty diagnostics firm GTI Diagnostics from equity firm Riverside Company for $53 million in cash. The company has funded the acquisition with its available cash. GTI Diagnostics...

California-based diagnostic products maker Gen-Probe Inc (GPRO) has acquired Wisconsin-based privately-held specialty diagnostics firm GTI Diagnostics from equity firm Riverside Company for $53 million in cash. The company has funded the acquisition with its available cash. GTI Diagnostics...

After months of wooing Cypress Bioscience (CYPB), Ramius LLC finally has reached an agreement with Cypress Bio's board. Cypress Bio entered into a definitive merger with Ramius V&O Acquisition LLC, an affiliate of Ramius and affiliates of Royalty Pharma. Terms of the Agreement Per the...

After months of wooing Cypress Bioscience (CYPB), Ramius LLC finally has reached an agreement with Cypress Bio's board. Cypress Bio entered into a definitive merger with Ramius V&O Acquisition LLC, an affiliate of Ramius and affiliates of Royalty Pharma. Terms of the Agreement Per the...

Here is a quick peek at stocks that have abnormally high daily put/call ratios today relative to their average…. 1. Pacific Sunwear (NASDAQ: PSUN) 2,692 puts, 40 calls 2. Lorillard Inc. (NYSE: LO) 4,182 puts, 168 calls 3. Corinthian Colleges (NASDAQ: COCO) 9,791 puts, 435 calls 4. Eli Lilly and Co...

We upgraded our recommendation on Monsanto Company (MON) from Underperform to Neutral based on improved visibility on the yield performance of SmartStax corn seed and RR2Y (Roundup Ready 2 Yield) soybean seed in the coming years. SmartStax and RR2Y posted a decent yield on completion of 95%...